FDA Authorizes Moderna’s COVID-19 Vaccine For Emergency Use
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine, as expected after an independent panel commissioned by the administration recommended its approval earlier this week.
The vaccine’s emergency authorization brings the second drug to prevent Covid-19 to the American public within a week, and millions of doses are expected to begin immediate distribution to health workers and long-term care residents.
Moderna’s vaccine is 94% effective at preventing Covid-19, and is authorized in adults 18 and older. The authorization comes after it was recommended by an FDA advisory panel of independent experts.
“With the availability of two vaccines now for the prevention of Covid-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing vast numbers of hospitalizations and deaths in the United States each day,” said Stephen Hahn, the FDA Commissioner, in a statement announcing the emergency authorization.